2 Global Nucleic Acid Testing Quarterly Market Size Analysis

• 2.1 Nucleic Acid Testing Business Impact Assessment - COVID-19
  • 2.1.1 Global Nucleic Acid Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Nucleic Acid Testing Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Nucleic Acid Testing Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Nucleic Acid Testing Headquarters and Area Served
• 3.3 Date of Key Players Enter into Nucleic Acid Testing Market
• 3.4 Key Players Nucleic Acid Testing Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Nucleic Acid Testing Segments, By Type

• 4.1 Introduction
  • 1.4.1 Transcription-mediated Amplification (TMA)
  • 1.4.2 Polymerase Chain Reaction (PCR)
  • 1.4.3 Ligase Chain Reaction (LCR)
  • 1.4.4 Whole Genome Sequencing
• 4.2 By Type, Global Nucleic Acid Testing Market Size, 2019-2021

5 Impact of Covid-19 on Nucleic Acid Testing Segments, By Application

• 5.1 Overview
  • 5.5.1 Hospitals
  • 5.5.2 Pathology Laboratories
  • 5.5.3 Research Institutes
  • 5.5.4 Clinics
• 5.2 By Application, Global Nucleic Acid Testing Market Size, 2019-2021
  • 5.2.1 By Application, Global Nucleic Acid Testing Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Agilent Technologies
  • 7.1.1 Agilent Technologies Business Overview
  • 7.1.2 Agilent Technologies Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.1.3 Agilent Technologies Nucleic Acid Testing Product Introduction
  • 7.1.4 Agilent Technologies Response to COVID-19 and Related Developments
• 7.2 Danaher Corporation
  • 7.2.1 Danaher Corporation Business Overview
  • 7.2.2 Danaher Corporation Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.2.3 Danaher Corporation Nucleic Acid Testing Product Introduction
  • 7.2.4 Danaher Corporation Response to COVID-19 and Related Developments
• 7.3 Abbott Laboratories, Inc.
  • 7.3.1 Abbott Laboratories, Inc. Business Overview
  • 7.3.2 Abbott Laboratories, Inc. Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.3.3 Abbott Laboratories, Inc. Nucleic Acid Testing Product Introduction
  • 7.3.4 Abbott Laboratories, Inc. Response to COVID-19 and Related Developments
• 7.4 Becton, Dickinson
  • 7.4.1 Becton, Dickinson Business Overview
  • 7.4.2 Becton, Dickinson Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.4.3 Becton, Dickinson Nucleic Acid Testing Product Introduction
  • 7.4.4 Becton, Dickinson Response to COVID-19 and Related Developments
• 7.5 Bio-Rad Laboratories
  • 7.5.1 Bio-Rad Laboratories Business Overview
  • 7.5.2 Bio-Rad Laboratories Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.5.3 Bio-Rad Laboratories Nucleic Acid Testing Product Introduction
  • 7.5.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
• 7.6 Roche
  • 7.6.1 Roche Business Overview
  • 7.6.2 Roche Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.6.3 Roche Nucleic Acid Testing Product Introduction
  • 7.6.4 Roche Response to COVID-19 and Related Developments
• 7.7 Illumina, Inc
  • 7.7.1 Illumina, Inc Business Overview
  • 7.7.2 Illumina, Inc Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.7.3 Illumina, Inc Nucleic Acid Testing Product Introduction
  • 7.7.4 Illumina, Inc Response to COVID-19 and Related Developments
• 7.8 Thermo Fisher Scientific Inc.
  • 7.8.1 Thermo Fisher Scientific Inc. Business Overview
  • 7.8.2 Thermo Fisher Scientific Inc. Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.8.3 Thermo Fisher Scientific Inc. Nucleic Acid Testing Product Introduction
  • 7.8.4 Thermo Fisher Scientific Inc. Response to COVID-19 and Related Developments
• 7.9 Merck KGaA
  • 7.9.1 Merck KGaA Business Overview
  • 7.9.2 Merck KGaA Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.9.3 Merck KGaA Nucleic Acid Testing Product Introduction
  • 7.9.4 Merck KGaA Response to COVID-19 and Related Developments
• 7.10 Qiagen
  • 7.10.1 Qiagen Business Overview
  • 7.10.2 Qiagen Nucleic Acid Testing Quarterly Revenue, 2020
  • 7.10.3 Qiagen Nucleic Acid Testing Product Introduction
  • 7.10.4 Qiagen Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US

This report covers market size and forecasts of Nucleic Acid Testing, including the following market information:
Global Nucleic Acid Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Nucleic Acid Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Nucleic Acid Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Nucleic Acid Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Agilent Technologies, Danaher Corporation, Abbott Laboratories, Inc., Becton, Dickinson, Bio-Rad Laboratories, Roche, Illumina, Inc, Thermo Fisher Scientific Inc., Merck KGaA, Qiagen, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Transcription-mediated Amplification (TMA)
Polymerase Chain Reaction (PCR)
Ligase Chain Reaction (LCR)
Whole Genome Sequencing

Based on the Application:
Hospitals
Pathology Laboratories
Research Institutes
Clinics